Reaction
Leukaemic Infiltration reporting signals
As of the last recalculation, Leukaemic Infiltration appears in 138 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is ACALABRUTINIB (PRR 134.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Acalabrutinib | 10 | 134.1 | 134.2 |
| Obinutuzumab | 10 | 98.8 | 98.8 |
| Bendamustine Hcl | 9 | 93.6 | 93.6 |
| Blinatumomab | 6 | 90.6 | 90.7 |
| Pegaspargase | 6 | 77.2 | 77.3 |